10-Q: Surgery Partners Reports Mixed Q2, Higher 6-Month Loss

Surgery Partners, Inc. reported an 8.3% revenue increase and reduced Q2 net loss, but saw a higher net loss and decreased operating cash flow for the first six months of 2025.

Summary

• Total revenues for the second quarter of 2025 increased by 8.3% to $826.2 million, up from $762.1 million in Q2 2024.
• Net loss attributable to Surgery Partners, Inc. for Q2 2025 significantly improved to $2.5 million, compared to a $15.5 million net loss in Q2 2024.
• Adjusted EBITDA for Q2 2025 increased by 9.0% to $129.0 million, up from $118.3 million in Q2 2024.
• For the six months ended June 30, 2025, total revenues increased by 8.3% to $1,602.2 million, from $1,479.5 million in the prior year period.
• Net loss attributable to Surgery Partners, Inc. for the six months ended June 30, 2025, widened to $40.2 million, compared to a $27.9 million net loss for the same period in 2024.
• Net cash provided by operating activities for the six months ended June 30, 2025, decreased to $87.3 million, down from $123.5 million in the prior year period.
• The company acquired a controlling interest in four surgical facilities and two physician practices for $48.0 million cash, net of cash acquired, during the first six months of 2025.
• As of June 30, 2025, the company owned or operated 162 surgical facilities (143 ASCs and 19 surgical hospitals) across 30 states.
• Days adjusted same-facility revenues increased by 5.1% for both the three and six months ended June 30, 2025, driven by increases in case volumes and revenue per case.
• Long-term debt, less current maturities, increased to $3,465.2 million as of June 30, 2025, from $3,268.9 million at December 31, 2024.

Sentiment

Score: 4

Explanation: While Q2 showed strong revenue growth and a reduced net loss, the six-month period reflects a widening net loss and a decrease in cash generated from operations. Increased debt and interest expense, coupled with a full valuation allowance on deferred tax assets due to a cumulative pre-tax loss position, indicate underlying financial challenges despite operational growth.

Positives

• Second quarter 2025 revenues increased by 8.3% to $826.2 million, demonstrating strong top-line growth.
• Net loss attributable to Surgery Partners, Inc. for Q2 2025 significantly narrowed to $2.5 million, a substantial improvement from the $15.5 million loss in Q2 2024.
• Adjusted EBITDA grew by 9.0% to $129.0 million in Q2 2025, indicating improved operational efficiency and profitability before non-cash and non-recurring items.
• Days adjusted same-facility revenues increased by 5.1% for both the three and six months ended June 30, 2025, driven by a 3.4% increase in same-facility cases and a 1.6% increase in revenue per case in Q2.
• The company continues strategic acquisitions, adding four surgical facilities and two physician practices in the first half of 2025, expanding its network.

Negatives

• Net loss attributable to Surgery Partners, Inc. for the six months ended June 30, 2025, widened to $40.2 million, compared to a $27.9 million loss in the prior year period.
• Net cash provided by operating activities decreased by $36.2 million to $87.3 million for the six months ended June 30, 2025, primarily due to higher cash interest payments and working capital changes.
• Interest expense, net, significantly increased to $67.9 million in Q2 2025 (from $51.5 million in Q2 2024) and to $130.1 million for the six months ended June 30, 2025 (from $98.8 million in 6M 2024), driven by financing activities and maturity of interest rate swaps.
• The company recorded a full valuation allowance on its net deferred tax assets due to being in a cumulative three-year pre-tax loss position, indicating uncertainty about future tax benefit realization.
• Total long-term debt increased to $3,465.2 million as of June 30, 2025, from $3,268.9 million at December 31, 2024.

Risks

• Reductions in payments from government healthcare programs (Medicare, Medicaid) and private insurance payors.
• Inability to contract with private insurance payors on favorable terms.
• Changes in payor mix or surgical case mix that could negatively impact revenues.
• Failure to maintain or develop relationships with physicians, which are crucial for facility utilization.
• Impact of payor controls designed to reduce the number of surgical procedures.
• Challenges in integrating operations of acquired businesses and surgical facilities, attracting new physician partners, or acquiring additional facilities.
• Supply chain issues, including shortages or quality control problems with surgery-related products, equipment, and medical supplies.
• Intense competition for physicians, nurses, strategic relationships, acquisitions, and managed care contracts.
• Inability to attract and retain qualified healthcare professionals.
• Difficulties in enforcing non-compete restrictions against physicians.
• Managing material liabilities, known or unknown, incurred as a result of acquiring surgical facilities.
• Impact of current and future legislation and other healthcare public policy changes, including the One Big Beautiful Bill Act (OBBBA).
• Inability to comply with current healthcare laws and regulations.
• Adverse outcomes from legal and regulatory proceedings.
• Impact of cybersecurity attacks or intrusions.
• Changes in the regulatory, economic, and other conditions of the states where surgical facilities are located.
• High level of indebtedness and its impact on financial flexibility.
• Social and economic impact of a pandemic, epidemic, or outbreak of a contagious disease on the business.
• Future estimates of goodwill fair value could be adversely affected by material changes in assumptions, potentially leading to impairment charges.
• Broad economic factors, including recent changes in interest rates, inflation, supply chain risks, and market volatility, could negatively affect payor mix, increase lower margin services, reduce patient volumes, and diminish the ability to collect outstanding receivables.
• Deterioration of general economic conditions could harm access to capital and the ability to repay outstanding debt.

Future Outlook

Management believes that cash flows from operations, available cash, available capacity on its Revolver, and continued anticipated access to capital markets will be adequate to meet both short-term (12 months) and long-term (beyond 12 months) liquidity needs. The company is currently assessing the implications of the One Big Beautiful Bill Act (OBBBA) passed on July 4, 2025, which introduced significant changes to federally funded healthcare programs and made permanent key elements of the Tax Cuts and Jobs Act, though these changes are not expected to materially impact the financial statements for the period reported.

Management Comments

• We continue to focus on improving our same-facility performance, selectively acquiring established facilities, developing new facilities and pursuing other portfolio management initiatives.

Industry Context

The company operates in the U.S. healthcare sector, specifically focusing on surgical facilities (ASCs and surgical hospitals) and ancillary services. Its strategy of partnering with physicians and, in some cases, health care systems, aligns with a broader industry trend towards outpatient care and physician alignment. The mention of the One Big Beautiful Bill Act (OBBBA) highlights the ongoing impact of legislative changes on federally funded healthcare programs, a constant factor in the U.S. healthcare landscape. The company's diversified surgical case mix across specialties like orthopedics, ophthalmology, and gastroenterology aims to mitigate risks from adverse trends in any single procedure type, reflecting a common risk management strategy in the multi-specialty healthcare provider space.

Corporate Governance

Legal Proceedings

• The company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices, and personal injuries.
• Management believes that no current proceedings would have a material adverse effect on the company's business, financial condition, or results of operations.

Stakeholder Impact

• Shareholders: Mixed financial results with Q2 improvements but increased 6-month net loss and debt, potentially impacting shareholder value and future profitability.
• Employees: Ongoing development initiatives and integration of acquisitions, along with severance costs, suggest potential shifts in workforce structure.
• Customers (Patients): Continued focus on expanding surgical facilities and services aims to enhance access to care.
• Suppliers: Supply chain issues are noted as a risk, which could impact operational efficiency and costs.
• Creditors: Increased long-term debt and higher interest expense indicate a growing debt burden, though management believes liquidity is adequate to meet obligations.

Next Steps

• Assess the implications of the One Big Beautiful Bill Act (OBBBA) on the company's financial statements.
• Continue focus on improving same-facility performance.
• Selectively acquire established facilities.
• Develop new facilities.
• Pursue other portfolio management initiatives.

Key Dates

Recommendation

While Surgery Partners demonstrates strong revenue and Adjusted EBITDA growth, particularly in Q2, the widening net loss for the six-month period and a decline in operating cash flow are concerning. The increase in debt and interest expense, coupled with the establishment of a full valuation allowance on deferred tax assets, signals financial headwinds. The company's strategic acquisitions and same-facility growth are positive, but the path to sustained profitability and improved cash generation remains challenged. A 'hold' recommendation is appropriate as the company navigates these mixed signals, with potential for long-term growth offset by current financial pressures and risks.

Keywords

Healthcare, Surgical Facilities, Ambulatory Surgery Centers, ASCs, Surgical Hospitals, Healthcare Services, Financial Results, SEC Filing, 10-Q, Earnings, Revenue, EBITDA, Acquisitions, Debt, Risk Factors